RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Pediatric preclinical testing consortium evaluation of the CD123 antibody drug conjugate, IMGN632, against xenograft models of pediatric acute lymphoblastic leukemia
Evans, K., El-Zein, N., Jones, C., Erickson, S. W., Guo, Y., Teicher, B. A., Adams, S., Zweidler-McKay, P. A., Smith, M. A., & Lock, R. B. (2019). Pediatric preclinical testing consortium evaluation of the CD123 antibody drug conjugate, IMGN632, against xenograft models of pediatric acute lymphoblastic leukemia. Cancer Research, 79(13). https://doi.org/10.1158/1538-7445.AM2019-4820